Alnylam PharmaceuticalsALNY 
$274.950.18%24h
0.18%24h
Global rank529
Market cap$34.34B
Change 7d3.11%
YTD Performance44.80%
SP500 benchmarkOutperform
P/E-78.11
P/S18.78
Revenue$1.83B
Earnings-$440.24M
Dividend yield-
Main Sector
Healthcare
Alnylam Pharmaceuticals Revenue data
According to Alnylam Pharmaceuticals latest financial reports the company had revenue of $1.83B in 2023-12-31, a 76.23% increase from 2022. Alnylam Pharmaceuticals highest revenue was $1.83B in 2023.
Revenue history for Alnylam Pharmaceuticals from 2020 to 2024
-
Value:-
Alnylam Pharmaceuticals revenue by year
| Year | Revenue | Change |
|---|---|---|
| 2023 | $1.83B | 76.23% |
| 2022 | $1.04B | 22.88% |
| 2021 | $844.29M | 71.31% |
| 2020 | $492.85M | - |
View the top revenue stocks 
